Magnetism-mediated targeting hyperthermia-immunotherapy in “cold” tumor with CSF1R inhibitor

Background: Immunotherapy has profoundly changed the landscape of cancer management and represented the most significant breakthrough. Yet, it is a formidable challenge that the majority of cancers - the so-called “cold” tumors - poorly respond to immunotherapy. To find a general immunoregulatory mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yuefei, He, Yang, Wu, Canhao, Zhang, Meng, Gu, Zeyun, Zhang, Jiaxin, Liu, Ergang, Xu, Qin, Asrorov, Akmal M., Huang, Yongzhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171105/
https://www.ncbi.nlm.nih.gov/pubmed/34093858
http://dx.doi.org/10.7150/thno.57511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171105/
https://www.ncbi.nlm.nih.gov/pubmed/34093858
http://dx.doi.org/10.7150/thno.57511

Ejemplares similares